Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-001818
Filing Date
2015-03-16
Accepted
2015-03-16 17:26:03
Documents
1
Period of Report
2015-02-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4021815traversa_actinium.html 4  
1 OWNERSHIP DOCUMENT f4021815traversa_actinium.xml 4 3935
  Complete submission text file 0001213900-15-001818.txt   5375
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 138 CANTERBURY LN BLUE BELL PA 19422
Business Address
TRAVERSA SERGIO (Reporting) CIK: 0001565832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 15704121